Bing

SEARCH HISTORY

U.K.-based GlaxoSmithKline (NYSE: GSK ) is no exception. Over the trailing 12-month period shareholders of GlaxoSmithKline stock have been privy to a nearly 6% yield – that's roughly three times better than the …
The Motley Fool · BySean Williams · 6/29/2015
GlaxoSmithKline
NEW YORK (TheStreet) -- GlaxoSmithKline (GSK - Get Report) shares are up 0.6% to $43.32 in pre-market trading on Monday after the healthcare company agreed to sell two of its meningitis vaccines to Pfizer (PFE) …
The Street · 6/22/2015
GlaxoSmithKline plc (LON:GSK)‘s stock had its “hold” rating reaffirmed by investment analysts at Jefferies Group in a note issued to investors on Thursday, Market Beat reports. They currently have a GBX 1,350 ($21.19) target price on the stock.
Ticker Report · 7/2/2015
More from Bing News
Perrigo Company (PRGO): PRGO stock is up 1.7% today. Opko Health Inc (OPK): OPK stock is up 1.6% today. Glaxosmithkline Plc (GSK): GSK stock is up 1.4% today. Abbvie Inc. Common Stock (ABBV): ABBV stock is up 1.5% today. Astrazeneca …
Investor Place · 7/1/2015
Shares of GlaxoSmithKline plc (LON:GSK) opened at 1348.50 on Thursday. GlaxoSmithKline plc has a one year low of GBX 1,296.50 and a one year high of GBX 1,645.00. The stock’s 50-day moving average is GBX 1,404.59 and its 200-day moving …
sleekmoney.com · 7/2/2015
GlaxoSmithKline (LSE: GSK), SABMiller (LSE ... Business seems certain Dignity is the UK's only stock market listed provider of funeral-related services, and ongoing business seems more certain than in any other …
Yahoo Finance UK and Ireland · 7/2/2015
GlaxoSmithKline plc
GSK is selling Nimenrix and Mencevax for about $130 million ... and has Zacks Momentum Style Score of “A.” Taking a quick look at the stock chart for NVO, shares broke through a consolidation period from late 2014 to February of this year.
ZACKS · 6/23/2015
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report GLAXOSMITHKLINE (GSK): Free Stock Analysis Report
Yahoo Finance · 6/23/2015
GSK) in a report issued on Tuesday. They currently have a GBX 1,410 ($22.38) target price on the stock. Several other analysts have also recently commented on the stock. Analysts at BNP Paribas reiterated an underperform rating and set a GBX 1,380 …
Mideast Times · 6/23/2015
GlaxoSmithKline plc
but no statement has yet been released by either regarding the speculation. GlaxoSmithKline stock closed 0.91% higher at $43.45 in Monday’s trade, while Pfizer stock was up 0.38% to close at $34.31.
bidnessetc.com · 6/23/2015

GlaxoSmithKline

Company
GlaxoSmithKline plc is a British multinational pharmaceutical company headquartered in Brentford, London. It was the world'…
GlaxoSmithKline plc is a British multinational pharmaceutical company headquartered in Brentford, London. It was the world's sixth-largest pharmaceutical company in 2014, after Pfizer, Novartis, Sanofi, Hoffmann-La Roche and Merck. It was established in 2000 by a merger of Glaxo Wellcome and SmithKline Beecham.
Data from: Wikipedia